• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较氨基糖苷类药物和 PTC124 对挽救与长 QT 综合征相关的 HERG 基因无义突变的通读效果。

Comparison of read-through effects of aminoglycosides and PTC124 on rescuing nonsense mutations of HERG gene associated with long QT syndrome.

机构信息

State Key Laboratory of Cardiovascular Disease, Physiology and Pathophysiology Laboratory, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, P.R. China.

出版信息

Int J Mol Med. 2014 Mar;33(3):729-35. doi: 10.3892/ijmm.2013.1601. Epub 2013 Dec 23.

DOI:10.3892/ijmm.2013.1601
PMID:24366185
Abstract

Aminoglycosides promote the readthrough of premature stop codons introduced by nonsense mutations to produce full-length proteins in genetic disease models. The read-through effects of different aminoglycosides and PTC124 on HERG gene have yet to be adequately elucidated. The wild-type (WT) or mutant genes were transiently transfected in HEK293 cells. The read-through effect was examined by adding drugs into culture medium for 24 h. Western blot analysis and patch clamping were performed to evaluate the expression and function of the genes. The mRNA levels were determined using qPCR. The results showed that G418 and PTC124 significantly increased the protein expression of R1014X mutant in a dose-dependent manner and produced a full-length protein. The maximal protein levels after G418, gentamicin or PTC124 treatment were 39.1±2.4, 18.6±0.3 or 10.3±1.0%, respectively, of the WT level. Tobramycin did not exhibit a read-through effect. The mRNA levels, however, did not differ between WT and mutant gene. The tail current densities of R1014X channels at 40 mV were 22.57±2.26 pA/pF for G418, 16.21±1.49 pA/pF for gentamicin and 9.62±0.73 pA/pF for PTC124. The leftward shift of the activation curve was corrected only by G418 and gentamicin. The read-through effects of W927X, R863X and E698X revealed that as the mutation site approached the N-terminal, the rescue efficiency was decreased. The above results suggest that aminoglycosides and PTC124 induced different effects on rescue nonsense mutations of the HERG gene. The mutation site was a significant factor in determining the pharmacological rescue efficiency.

摘要

氨基糖苷类抗生素可促进无义突变引起的提前终止密码子通读,从而在遗传疾病模型中产生全长蛋白。不同的氨基糖苷类抗生素和 PTC124 对 HERG 基因的通读效果尚未得到充分阐明。将野生型(WT)或突变基因瞬时转染至 HEK293 细胞中。通过在培养物中添加药物 24 小时来检测通读效果。通过 Western blot 分析和膜片钳技术评估基因的表达和功能。使用 qPCR 测定 mRNA 水平。结果表明,G418 和 PTC124 以剂量依赖性方式显著增加 R1014X 突变体的蛋白表达,并产生全长蛋白。G418、庆大霉素或 PTC124 处理后的最大蛋白水平分别为 WT 水平的 39.1±2.4%、18.6±0.3%和 10.3±1.0%。妥布霉素则没有通读效果。然而,WT 和突变基因之间的 mRNA 水平没有差异。在 40 mV 时,R1014X 通道的尾电流密度分别为 G418 组 22.57±2.26 pA/pF、庆大霉素组 16.21±1.49 pA/pF 和 PTC124 组 9.62±0.73 pA/pF。只有 G418 和庆大霉素能纠正激活曲线的左移。W927X、R863X 和 E698X 的通读效果表明,随着突变部位接近 N 端,挽救效率降低。上述结果表明,氨基糖苷类抗生素和 PTC124 对 HERG 基因无义突变的挽救效果不同。突变部位是决定药物挽救效率的重要因素。

相似文献

1
Comparison of read-through effects of aminoglycosides and PTC124 on rescuing nonsense mutations of HERG gene associated with long QT syndrome.比较氨基糖苷类药物和 PTC124 对挽救与长 QT 综合征相关的 HERG 基因无义突变的通读效果。
Int J Mol Med. 2014 Mar;33(3):729-35. doi: 10.3892/ijmm.2013.1601. Epub 2013 Dec 23.
2
Aminoglycoside antibiotics restore functional expression of truncated HERG channels produced by nonsense mutations.氨基糖苷类抗生素可恢复由无义突变产生的截短型HERG通道的功能表达。
Heart Rhythm. 2009 Apr;6(4):553-60. doi: 10.1016/j.hrthm.2009.01.017. Epub 2009 Jan 21.
3
Stop codons and the +4 nucleotide may influence the efficiency of G418 in rescuing nonsense mutations of the HERG gene.终止密码子和+4 个核苷酸可能影响 G418 拯救 HERG 基因突变的效率。
Int J Mol Med. 2019 Dec;44(6):2037-2046. doi: 10.3892/ijmm.2019.4360. Epub 2019 Oct 1.
4
Nonsense mutations in hERG cause a decrease in mutant mRNA transcripts by nonsense-mediated mRNA decay in human long-QT syndrome.人源ether-à-go-go相关基因(hERG)中的无义突变通过无义介导的mRNA降解导致人类长QT综合征中突变mRNA转录本减少。
Circulation. 2007 Jul 3;116(1):17-24. doi: 10.1161/CIRCULATIONAHA.107.708818. Epub 2007 Jun 18.
5
Defective assembly and trafficking of mutant HERG channels with C-terminal truncations in long QT syndrome.长QT综合征中C末端截短的突变HERG通道的组装和运输缺陷。
J Mol Cell Cardiol. 2004 Dec;37(6):1225-33. doi: 10.1016/j.yjmcc.2004.10.002.
6
Early LQT2 nonsense mutation generates N-terminally truncated hERG channels with altered gating properties by the reinitiation of translation.早期 LQT2 无义突变通过翻译的重新起始产生具有改变的门控特性的 N 端截断的 hERG 通道。
J Mol Cell Cardiol. 2012 Nov;53(5):725-33. doi: 10.1016/j.yjmcc.2012.08.021. Epub 2012 Sep 3.
7
Position of premature termination codons determines susceptibility of hERG mutations to nonsense-mediated mRNA decay in long QT syndrome.过早终止密码子的位置决定了长 QT 综合征中 hERG 突变对无意义介导的 mRNA 降解的易感性。
Gene. 2014 Apr 15;539(2):190-7. doi: 10.1016/j.gene.2014.02.012. Epub 2014 Feb 13.
8
Readthrough of long-QT syndrome type 1 nonsense mutations rescues function but alters the biophysical properties of the channel.长 QT 综合征 1 型无义突变的通读可恢复功能,但改变了通道的生物物理特性。
Biochem J. 2012 May 1;443(3):635-42. doi: 10.1042/BJ20111912.
9
Nonsense-Mediated mRNA Decay of hERG Mutations in Long QT Syndrome.长QT综合征中hERG突变的无义介导的mRNA降解
Methods Mol Biol. 2018;1684:37-49. doi: 10.1007/978-1-4939-7362-0_4.
10
Identification and functional characterization of the human ether-a-go-go-related gene Q738X mutant associated with hereditary long QT syndrome type 2.与遗传性2型长QT综合征相关的人ether-a-go-go相关基因Q738X突变体的鉴定及功能表征
Int J Mol Med. 2014 Sep;34(3):810-5. doi: 10.3892/ijmm.2014.1827. Epub 2014 Jul 1.

引用本文的文献

1
Development of translational read-through-inducing drugs as novel therapeutic options for patients with Fanconi anemia.开发诱导翻译通读的药物作为范可尼贫血患者的新型治疗选择。
Cell Death Discov. 2025 Jun 21;11(1):286. doi: 10.1038/s41420-025-02571-0.
2
When -caused LQT2 encounters antisense oligonucleotide: is exon 6 skipping therapy plausible?当由-caused引起的LQT2遇到反义寡核苷酸时:外显子6跳跃疗法是否可行? (注:这里“-caused”表述不太准确完整,可能原文有误,但按要求逐字翻译了)
Front Pharmacol. 2025 Mar 21;16:1535259. doi: 10.3389/fphar.2025.1535259. eCollection 2025.
3
A W1282X cystic fibrosis mouse allows the study of pharmacological and gene-editing therapeutics to restore CFTR function.
一只携带W1282X突变的囊性纤维化小鼠可用于研究恢复CFTR功能的药理学和基因编辑疗法。
J Cyst Fibros. 2025 Jan;24(1):164-174. doi: 10.1016/j.jcf.2024.10.008. Epub 2024 Nov 12.
4
A Novel S981fs Mutation Identified by Whole-Exome Sequencing Is Associated with Type 2 Long QT Syndrome.全外显子组测序鉴定的新型 S981fs 突变与 2 型长 QT 综合征相关。
Int J Mol Sci. 2023 Aug 13;24(16):12742. doi: 10.3390/ijms241612742.
5
A Simple and Affordable Method to Create Nonsense Mutation Clones of p53 for Studying the Premature Termination Codon Readthrough Activity of PTC124.一种简单且经济实惠的方法,用于创建p53的无义突变克隆,以研究PTC124的提前终止密码子通读活性。
Biomedicines. 2023 Apr 28;11(5):1310. doi: 10.3390/biomedicines11051310.
6
PTC124 Rescues Nonsense Mutation of Two Tumor Suppressor Genes and to Repress HNSCC Cell Proliferation.PTC124挽救两个肿瘤抑制基因的无义突变并抑制头颈部鳞状细胞癌(HNSCC)细胞增殖。
Biomedicines. 2022 Nov 16;10(11):2948. doi: 10.3390/biomedicines10112948.
7
Ataluren-Promising Therapeutic Premature Termination Codon Readthrough Frontrunner.阿他芦仑——有前景的治疗性提前终止密码子通读领先药物。
Pharmaceuticals (Basel). 2021 Aug 9;14(8):785. doi: 10.3390/ph14080785.
8
Nonsense suppression therapies in human genetic diseases.无义抑制疗法在人类遗传疾病中的应用。
Cell Mol Life Sci. 2021 May;78(10):4677-4701. doi: 10.1007/s00018-021-03809-7. Epub 2021 Mar 22.
9
Synergy between Readthrough and Nonsense Mediated Decay Inhibition in a Murine Model of Cystic Fibrosis Nonsense Mutations.在囊性纤维化无义突变小鼠模型中,通读与无义介导的衰变抑制之间的协同作用。
Int J Mol Sci. 2020 Dec 31;22(1):344. doi: 10.3390/ijms22010344.
10
Nonsense Suppression Therapy: New Hypothesis for the Treatment of Inherited Bone Marrow Failure Syndromes.无义抑制疗法:遗传性骨髓衰竭综合征治疗的新假说。
Int J Mol Sci. 2020 Jun 30;21(13):4672. doi: 10.3390/ijms21134672.